Patrice Viens
About
In The Last Decade
Patrice Viens
342 papers receiving 17.1k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 10.5k
- Molecular Biology 6.0k
- Cancer Research 5.6k
- Pulmonary and Respiratory Medicine 2.8k
- Immunology 2.2k
Countries citing papers authored by Patrice Viens
This map shows the geographic impact of Patrice Viens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice Viens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice Viens more than expected).
Fields of papers citing papers by Patrice Viens
This network shows the impact of papers produced by Patrice Viens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice Viens. The network helps show where Patrice Viens may publish in the future.
Co-authorship network of co-authors of Patrice Viens
This figure shows the co-authorship network connecting the top 25 collaborators of Patrice Viens. A scholar is included among the top collaborators of Patrice Viens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrice Viens. Patrice Viens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 9 | |
| 4 | 171 | |
| 5 | 1 | |
| 6 | Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors. | 15 |
| 7 | 331 | |
| 8 | Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer breakdown → | 575 |
| 9 | Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature breakdown → | 935 |
| 10 | 96 | |
| 11 | 221 | |
| 12 | 218 | |
| 13 | 107 | |
| 14 | 174 | |
| 15 | Typage moléculaire du cancer du sein : transcriptome et puces à ADN | 1 |
| 16 | Intratumoral injection of cisplatin epinephrine gel for palliation of dysphagia in patients with advanced esophageal cancer | 2 |
| 17 | 43 | |
| 18 | Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expression. | 37 |
| 19 | Efficacité antalgique du kétoprofène en perfusion continue dans les douleurs rebelles par métastases osseuses. | 1 |
| 20 | Schistosomiase intestinale. Précocité de l'atteinte hépatique avec hypertension portale: étude de cinq cas. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.